DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

TRIB stock opened at $0.64 on Wednesday. Trinity Biotech has a one year low of $0.48 and a one year high of $3.55. The firm has a 50-day moving average of $0.65 and a two-hundred day moving ...

Trinity Biotech plc (NASDAQ:TRIB), a leading developer of diagnostic products for the healthcare industry trading near its 52-week low of $0.56, today announced a significant change in its ...

DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Trinity Biotech plc (NASDAQ:TRIB), a leading developer of diagnostic products for the healthcare industry trading near its 52-week low of $0.56, today announced a significant change in its executive ...

The firm has a market cap of $10.47 million, a P/E ratio of -0.26 and a beta of 1.21. Trinity Biotech has a 12 month low of $0.48 and a 12 month high of $3.55. The stock has a 50-day moving ...

Trinity Biotech PLC (TRIB) reports a 3% revenue increase and outlines strategic initiatives for future growth and profitability. Trinity Biotech PLC (TRIB) reports a 14% revenue increase with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...